Dr. Sandy Feng, MD

Dr. Feng practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Feng's NPI, 1114981594, was assigned on April 13, 2006. Dr. Feng graduated from Stanford University School Of Medicine in 1990. Dr. Feng holds California license G83048.

Dr. Feng's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Feng's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Medical Group. Dmand AI also links Dr. Feng to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feng practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Feng's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Feng is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Feng's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists gastrointestinal bleeding, gastrointestinal obstruction and kidney transplant among the conditions Dr. Feng treats.

CMS data shows 62 Medicare services from Dr. Feng across 2 procedure codes in 2024, for 65 Medicare patients. Medicare paid $6,730 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Feng in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 74% have chronic kidney disease. 49% are also on Medicaid. Their average risk score is 5.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Feng's median patient age at 58, with 46% women.

In 2024, Dr. Feng wrote 133 Medicare Part D claims for 36 patients. 89% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $221 in total drug cost. In 2023, CMS named 95 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Feng for performance year 2024, reported as part of a group. Dr. Feng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Feng as offering telehealth.

Dmand AI links 173 papers to Dr. Feng, published from 2004 to 2025. 2022 was the busiest year, with 9. The most frequent topics are Liver Transplantation, Graft Rejection and Graft Survival. Dr. Feng has published most often in Am J Transplant. Dr. Feng's most frequent co-authors are Chris E. Freise, MD, Jennifer C. Lai, MBA, MD and John P. Roberts, MD.

Dmand AI links Dr. Feng to 7 clinical trials, 2 of them phase 1 studies. Conditions studied include Hepatorenal Syndrome and Liver Diseases. National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most, 6.

CMS Open Payments shows 18 general payments to Dr. Feng from 3 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 71% of the total. CSL Behring paid the most, $3,771.

Dmand AI lists 2 awards for Dr. Feng, most recently CMS Stage 1 EHR in 2013.

Dr. Feng graduated from Stanford University School Of Medicine in 1990.

Dr. Feng is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.